420 with CNW — US DOJ Moves Some Marijuana Products to Schedule III
The Justice Department (DOJ) has rescheduled certain marijuana products, signaling a notable policy shift after decades of strict federal control. Acting AG Todd Blanche announced that cannabis products approved by the FDA or authorized under state medical cannabis programs will be moved from Schedule I to Schedule III. This adjustment places them alongside medications such as codeine-based pain relievers, reflecting a lower perceived risk and recognized medical use. Blanche also directed officials to begin a formal review that could lead to broader changes, including the possible reclassification of cannabis in its entirety. A public hearing has been scheduled for June…

















